This is unpublished
ProActive
Active Studies
Transplantation
Pinned
Principal Investigator
Nicolae Leca, MD
Funding Agency
Sponsor: Natera, Inc.
Status
Active
Enrollment closed
Investigator
What is the proactive Study?
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) Study. Determine the utility of Prospera testing compared to usual creatinine testing as measured by the proportion of positive biopsies in post renal allograft patients.
What are the criteria for the study?
18 years of age or older; renal allograft up to 2 years prior to signing ICF; newly transplanted patients to receive Prospera testing within 60 days of transplant.
WHO DO I CONTACT FOR MORE INFORMATION?
Research Coordinator
Belinda Pan
E: bcpan@uw.edu